MET and neoplasm: Meanwhile, Met is a receptor tyrosine kinase family member encoded by the proto-oncogene Met. Abnormal activation of Met in cancer is correlated with poor prognosis, likely because aberrantly active Met triggers tumor growth, angiogenesis, and metastasis32–35.